Patogénesis de las enfermedades neuronales autoinmunes
Publicaciones destacadas
-
Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease
Gaig, Carles; Compta, Yaroslau; Heidbreder, Anna; Marti, Maria J; Titulaer, Maarten J;(...)Sabater, Lidia; Iranzo, Alex; Cano, Joan Santamaria; Dalmau, Josep; Graus, Francesc.Referencia:Neurology 2021.
-
Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2
Landa, J; Guasp, M; Planagumà, J; Martínez-Hernández, E; Armangué, T;(...)Krajinovic, V; Fuhr, P; Honnorat, J; Titulaer, M; Simabukuro, M.Referencia:Annals Of Neurology 2021.
-
Placental transfer of NMDAR antibodies causes reversible alterations in mice
García-Serra, A; Radosevic, M; Pupak, A; Brito, V; Aguilar, E;(...)Joubert, B; Ginés, S; Planagumà, J; Dalmau, J; Ríos, J.Referencia:Neurology-Neuroimmunology & Neuroinflammation 2021.
-
Sleep disorders in autoimmune encephalitis
Munoz-Lopetegi, Amaia; Graus, Francesc; Dalmau, Josep; Santamaria, Joan;Referencia:Lancet Neurology 2020.
-
Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis
Spatola, Marianna; Pedrol, Mar Petit; Maudes, Estibaliz; Simabukuro, Mateus; Muniz-Castrillo, Sergio;(...)Smitt, Peter Sillevis; Honnorat, Jerome; Rosenfeld, Myrna R; Graus, Francesc; Dalmau, Josep.Referencia:Neurology 2020.
-
Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis
Mannara, Francesco; Radosevic, Marija; Planaguma, Jesus; Soto, David; Aguilar, Esther;(...)Quirk, Michael; Dai, Jing; Gasul, Xavier; Lewis, Mike; Dalmau, Josep.Referencia:Brain 2020.
-
Reduced serial dependence suggests deficits in synaptic potentiation in anti-NMDAR encephalitis and schizophrenia
Stein, Heike; Barbosa, Joao; Rosa-Justicia, Mireia; Prades, Laia; Morato, Alba;(...)Arino, Helena; Martinez-Hernandez, Eugenia; Castro-Fornieles, Josefina; Dalmau, Josep; Compte, Albert.Referencia:Nature Communications 2020.
-
Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study
Armangue, T; Olivé-Cirera, G; Martínez-Hernandez, E; Sepulveda, M; Muñoz-Batista, M;(...)Arrambide, G; Tintoré, M; Montalban, X; Auger, C; Vanderver, A.Referencia:Lancet Neurology 2020.